Off-off label
Ever heard of off-off Broadway shows? The ones that really don't have much to do with "Broadway" at all? Well, medicine has its own version: "off-off label" uses for drugs. You see, there's regular "off-label," where a drug is used to treat something other than the condition it's intended for. And then there's "off-off label," like the kind I read about in a recent article: "Antimalarial drug prevents diabetes in arthritis patients, study suggests." In this latest example, researchers discovered that patients being treated with the anti-malaria drug hydroxychloroquine (HCQ) for cases of rheumatoid arthritis (off label use No.1) also had a 53 percent lower risk of developing diabetes. Basically, I'd define "off-off label" as a completely convoluted way to treat a patient. Unfortunately, mainstream medicine doesn't share my opinion. The lead researcher of the study I mentioned above presented his findings at the Annual Scientific Meeting of the American College of Rheumatology last October, and he concluded that "We should revisit HCQ in the treatment of rheumatoid arthritis because, in addition to its disease- modifying properties, it might prevent the development of diabetes in this high-risk group." You know what else might prevent diabetes in rheumatoid arthritis patients? The same approaches that prevent it in other people. Ones that don't involve drugs at all (off label or otherwise). For Dr. Wright's complete guide to preventing diabetes, refer to his report, "10 Natural Ways to Stop Diabetes in its Tracks." You can learn more about it by visiting https://www.web-purchases.com/640SNNHDR/E6ETK1ZC/landing.html. Source:
"Antimalarial drug prevents diabetes in arthritis patients, study suggests," ScienceDaily (www.sciencedaily.com), 10/31/08 | 
